Integra Lifesciences Holdings (IART) Cash from Discontinued Operations (2014 - 2015)
Integra Lifesciences Holdings recorded quarterly Cash from Discontinued Operations of 18937000.0 in Q2 2015, down 381.47% quarter-over-quarter from 6728000.0 in Q1 2015.
Integra Lifesciences Holdings' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 18937000.0 for Q2 2015.
- In Q2 2015, Cash from Discontinued Operations changed N/A year-over-year to 18937000.0; the TTM figure through Mar 2016 stood at 18937000.0 (changed N/A YoY), while the FY2015 annual figure was 12209000.0, down 159.21% from the prior year.
- Cash from Discontinued Operations came in at 18937000.0 for Q2 2015 at Integra Lifesciences Holdings, down from 6728000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 6728000.0 in Q1 2015 to a low of 18937000.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -18.94 Mn |
| Jun 30, 2015 | -18.94 Mn |
| Mar 31, 2015 | 6.73 Mn |
| Mar 31, 2015 | 6.73 Mn |
| Dec 31, 2014 | 2.86 Mn |
| Dec 31, 2014 | 2.86 Mn |